Marathon Capital Management Illumina, Inc. Transaction History

Marathon Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$181.58 - $368.0 $476,829 - $966,368	2,626 New	2,626 $484,000
Q1 2022 May 13, 2022	SELL	$303.87 - $423.8 $766,056 - $1.07 Million	-2,521 Closed	0 $0
Q4 2021 Feb 09, 2022	SELL	$347.28 - $421.83 $210,451 - $255,628	-606 Reduced 19.38%	2,521 $959,000
Q3 2021 Nov 15, 2021	BUY	$405.61 - $524.84 $251,883 - $325,925	621 Added 24.78%	3,127 $1.27 Million
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $37,284 - $48,150	-100 Reduced 3.84%	2,506 $1.19 Million
Q1 2021 May 14, 2021	SELL	$361.28 - $504.76 $3,612 - $5,047	-10 Reduced 0.38%	2,606 $1 Million
Q4 2020 Feb 08, 2021	BUY	$292.7 - $370.96 $114,445 - $145,045	391 Added 17.57%	2,616 $967,000
Q3 2020 Nov 16, 2020	BUY	$268.51 - $400.74 $597,434 - $891,646	2,225 New	2,225 $687,000

904

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

Stay updated on Marathon Capital Management with notifications on news.